Reacciones alérgicas por L-asparaginasa en niños con leucemia linfoide aguda

Machín García, Sergio Arturo; Rubio Blanco, Yainer; González Otero, Alejandro; Menéndez Veitía, Andrea; Gil Agramonte, Mildrey; Valdés Cabrera, Francisco.
Rev. cuba. hematol. inmunol. hemoter ; 35(1): e938, ene.-mar. 2019. graf
Artigo em Espanhol | LILACS, CUMED | ID: biblio-1042892

Documentos relacionados

  1. Tolerability and efficacy of L-asparaginase therapy in pediatric patients with acute lymphoblastic leukemia.
  2. Utility of <i>ASNS</i> gene methylation evaluated with the HPLC method as a pharmacogenomic biomarker to predict asparaginase sensitivity in BCP-ALL.
  3. Response surface methodology based optimized production, purification, and characterization of L-asparaginase from Fusarium foetens.
  4. [Iatrogenic hyperlipidemia after l-asparaginase and glucocorticoid treatment in two children with acute lymphoblastic leukemia].
  5. Depletion of d- and l-asparagine in cerebrospinal fluid in acute lymphoblastic leukemia during PEGasparaginase therapy.
  6. Polyoxazoline-Conjugated l-Asparaginase: An Antibody-Production-Free Therapeutic Agent for Acute Lymphoblastic Leukemia.
  7. A Patent Review on the Use of L-Asparaginase in the Treatment of Acute Lymphocytic Leukemia.
  8. Asparagine levels in the cerebrospinal fluid of children with acute lymphoblastic leukemia treated with pegylated-asparaginase in the induction phase of the AIEOP-BFM ALL 2009 study.
  9. L-Asparaginase delivery systems targeted to minimize its side-effects.
  10. Elucidation of the Active Form and Reaction Mechanism in Human Asparaginase Type III Using Multiscale Simulations.